Prognostic value of radiological recurrence patterns in ovarian cancer

被引:7
|
作者
Roze, Joline F. [1 ]
Veldhuis, Wouter B. [2 ]
Hoogendam, Jacob P. [1 ]
Verheijen, Rene H. M. [1 ]
Scholten, Rob J. P. M. [3 ]
Zweemer, Ronald P. [1 ]
机构
[1] Univ Utrecht, UMC Utrecht Canc Ctr, Dept Gynaecol Oncol, Univ Med Ctr Utrecht, Utrecht, Netherlands
[2] Univ Utrecht, Univ Med Ctr Utrecht, UMC Utrecht Canc Ctr, Dept Radiol, Utrecht, Netherlands
[3] Univ Utrecht, Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands
关键词
Ovarian cancer; Recurrence; Recurrence patterns; Imaging; CT scan; CYTOREDUCTIVE SURGERY; STATISTICS; CARCINOMA; SURVIVAL; IMPACT;
D O I
10.1016/j.ygyno.2020.03.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. To study the prognostic value of CT assessed recurrence patterns on survival outcomes in women with epithelial ovarian cancer. Methods. CT scans were systematically re-evaluated on predefined anatomical sites for the presence of tumor in all 89 patients diagnosed with epithelial ovarian cancer between January 2008 and December 2013 who underwent cytoreductive surgery at our institution and developed a recurrence. A Cox proportional hazard analysis was used to test the effect of recurrence patterns on survival. Results. The median survival time for patients grouped as predominantly intraperitoneal (n = 62), hematogenous (n = 13) or lymphatic (n = 14) recurrence was 25.8 (95% CI 18.4-33.2), 27.6 (95% CI 18.5-36.6) and 52.9 months (95% CI 42.1-63.7), respectively. Univariate Cox regression analysis identified the following prognostic factors: lymphatic recurrence pattern (HR 0.42, 95% CI 0.21-0.85), ascites at diagnosis (HR 2.35, 95% CI 1.46-3.79), residual tumor at initial surgery (HR 2.16, 95% CI 1.36-3.44) and FIGO stage (I-IIIB: HR 0.59, 95% CI 0.33-1.06). The median time to recurrence was 19.5 month for patients after complete debulking surgery, 13.1 months for patients with residual disease =1 cm and 8.2 months for patients with residual disease N1 cm after surgery (P b 0.001). No differences in recurrence patterns between patients with complete and incomplete surgery were found. Conclusions. Prolonged survival rates were found in ovarian cancer patients with a predominantly lymphatic recurrence compared to patients with a predominantly peritoneal or hematogenous recurrence. Completeness of surgerywas associatedwith time to recurrence. Classification of recurrence patterns can help counsel patients on their prognosis at the time of recurrence. (C) 2020 The Author(s). Published by Elsevier Inc.
引用
收藏
页码:606 / 612
页数:7
相关论文
共 50 条
  • [1] PROGNOSTIC VALUE OF RECURRENCE PATTERNS IN OVARIAN CANCER
    Roze, J. F.
    Hoogendam, J. P.
    Veldhuis, W. B.
    Scholten, R. J. P. M.
    Zweemer, R. P.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A514 - A515
  • [2] Retrospective Analysis of Radiological Recurrence Patterns in Glioblastoma, Their Prognostic Value And Association to Postoperative Infarct Volume
    Bette, Stefanie
    Barz, Melanie
    Huber, Thomas
    Straube, Christoph
    Schmidt-Graf, Friederike
    Combs, Stephanie E.
    Delbridge, Claire
    Gerhardt, Julia
    Zimmer, Claus
    Meyer, Bernhard
    Kirschke, Jan S.
    Boeckh-Behrens, Tobias
    Wiestler, Benedikt
    Gempt, Jens
    SCIENTIFIC REPORTS, 2018, 8
  • [3] Retrospective Analysis of Radiological Recurrence Patterns in Glioblastoma, Their Prognostic Value And Association to Postoperative Infarct Volume
    Stefanie Bette
    Melanie Barz
    Thomas Huber
    Christoph Straube
    Friederike Schmidt-Graf
    Stephanie E. Combs
    Claire Delbridge
    Julia Gerhardt
    Claus Zimmer
    Bernhard Meyer
    Jan S. Kirschke
    Tobias Boeckh-Behrens
    Benedikt Wiestler
    Jens Gempt
    Scientific Reports, 8
  • [4] Nadir CA-125 has prognostic value for recurrence, but not for survival in patients with ovarian cancer
    Szymon Piatek
    Grzegorz Panek
    Zbigniew Lewandowski
    Dominika Piatek
    Przemyslaw Kosinski
    Mariusz Bidzinski
    Scientific Reports, 11
  • [5] The diagnostic, prediction of postoperative recurrence and prognostic value of HE4 in epithelial ovarian cancer
    Chen, Longyi
    Yang, Xiuwei
    Abasi, Xiariwana
    Shapaer, Gulinaer
    Aizimu, Ayinuer
    Zhang, Shuping
    Wan, Yingxiang
    Kamaer, Xiamuxi
    Tuerxun, Tuoluniayi
    Abula, Reyihanguli
    Zhang, Qingyue
    JOURNAL OF BUON, 2018, 23 (02): : 428 - 432
  • [6] Nadir CA-125 has prognostic value for recurrence, but not for survival in patients with ovarian cancer
    Piatek, Szymon
    Panek, Grzegorz
    Lewandowski, Zbigniew
    Piatek, Dominika
    Kosinski, Przemyslaw
    Bidzinski, Mariusz
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [7] Prognostic Factors After the First Recurrence of Ovarian Cancer
    Salas Bolivar, Patricia
    Gonzalez-Benitez, Cristina
    Carbonell Lopez, Maria
    Diez Sebastian, Jesus
    Hernandez Gutierrez, Alicia
    Zapardiel, Ignacio
    JOURNAL OF CLINICAL MEDICINE, 2025, 14 (02)
  • [8] Prognostic value of clinical variables in ovarian cancer
    DiSilvestro, P
    Peipert, JF
    Hogan, JW
    Granai, CO
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 1997, 50 (05) : 501 - 505
  • [9] The prognostic value of peritoneal cytology in ovarian cancer
    Simojoki, M
    Santala, M
    Vuopala, S
    Kauppila, A
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 1999, 20 (5-6) : 357 - 360
  • [10] Prognostic value of circulating cytokines in colon cancer recurrence
    Kilzi, George M.
    Lavu, Harish
    JOURNAL OF SURGICAL RESEARCH, 2014, 186 (01) : 85 - 86